Scars are a common complication of surgery or burn wound management. Scars occur over the body, affecting people of both sexes and all ages. Scar therapy is a constant clinical challenge; antimitotic drugs and radiotherapy are used with varying degrees of success. This article examines the success of both these types of treatment modalities.
Haverstock BDHypertrophic scars and keloids. Clin Podiatr Med Surg. 2001;18:147-159.
2.
Bouchard J., May RMStathmokinetic test applied to the study of the physiology of mitosis in normal, cicatricial or cancerous epidermis. Arch Sci Physiol (Paris) . 1967; 21:153-183.
3.
Niessen FB, Spauwen PHM, Schalkwijk J., Kon M.On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104:1435.
4.
Bao Wei Han, Xu Shao Jun.Mechanism of steroid treatment on abnormal scars [in Chinese]. Chin J Surg. 2000; 38:378-381.
5.
Griffith BH, Monroe CW, McKinney PAFollow-up study on the treatment of keloids with triamcinolone acetonide . Plast Reconstr Surg. 1970;46:145-150.
6.
Rockwell WB, Cohen IK, Ehrlich HPKeloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg. 1989;84:827-837.
7.
Niessen FB, Spauwen PHM, Schalkwijk J., Kon M.On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104:1435-1458.
8.
Alster TS, West TBTreatment of scars: a review. Ann Plast Surg. 1997;39:418-432.
9.
Murray JCKeloids and hypertrophic scars. Clin Dermatol. 1994;12:27-37.
10.
Kelly APKeloids. Dermatol Clin. 1988;6:413-424.
11.
Murray JCScars and keloids. Dermatol Clin. 1993;11: 697-708.
12.
Manuskiatti W., Fitzpatrick RETreatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138:1149-1155.
13.
Urioste SS, Arndt KA, Dover JSKeloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg. 1999;18:159-171.
14.
De Waard JW , de Man BM, Wobbes T., et al. Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil . Eur J Cancer. 1998;34:162-167.
15.
Rechard EFTreatment of inflamed hypertrophic scar using interlesional 5-FU. Dermatol Surg. 1999;25: 224-232.
16.
Kontochristopoulos G., Stefanaki C., Panagiotopoulos A., et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52:474-479.
17.
Ying ZZThe efficacy of 5-FU and steroids to treat keloids [in Chinese]. J Tongji Univ. 2007;28:79-82.
18.
Asilian A., Darougheh A., Shariati F.New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg . 2006;32:907-915.
19.
Apikian M., Goodman G.Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol. 2004;45:140-143.
20.
Farahnaz FN , Najafian J., Ahmadpour K.Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars . Dermatol Surg. 2006;32: 1023-1030.
21.
Bodokh Y., Brun P.Treatment of keloid with intralesional bleomycin [in French]. Ann Dermatol Venereol. 1996; 123:791-794.
22.
Espana A., Solano T., Quintanilla E.Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27:23-27.
23.
Ribeiro FdA , Guaraldo L., Borges JdP , et al. Clinical and histological healing of surgical wounds treated with mitomycin C. Laryngoscope. 2004;114:148-152.
24.
Heath T., Eric RH, Joseph W.The effect of topical mitomycin C on full-thickness burns. Plast Reconstr Surg. 2007;15:879-886.
25.
Ghoshal K., Jacob STAn alternative molecular mechanism of action of 5-fluorouracil, a potent anti-cancer drug. Biochem Pharmacol. 1997;53:1569-1577.
26.
Blumenkranz MS , Claflin A., Hajek ASSelection of the therapeutic agents for intra-ocular proliferative disease: cell culture evaluation. Arch Ophthalmol . 1984;102:598-604.
27.
Wendling J. , Marchand A., Mauviel A., Verrecchia F.5-Fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase/activator protein-1 activation. Mol Pharmacol. 2003 ;64:707-713.
28.
Oikarinen H. , Oikarinen AI, Tan EM, et al. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen . J Clin Invest. 1985;75: 1545-1553.
29.
Guang ZU, sun Guang C.The determination of hydroxyproline in serum and urinary in patients with hypertrophic scar and its clinical significance [in Chinese]. J Chin Plast Surg. 1991;7:174-176.
30.
Abergel RP, Meeker CA, Oikarinen H., Oikarinen AI, Uitto J.Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures . Arch Dermatol. 1985;121:632-635.
31.
Peacock EE Jr.Pharmacologic control of surface scarring in human beings . Ann Surg. 1981;193:592-597.
32.
Joseph HL, Anderson GL, Barker JH, Roisen FJ, Weiner LJ, Tobin GRJ.Inhibition of wound contraction with colchicine and D-penicillamine . Surg Res. 1996;61: 197-200.
33.
Hua XR, Hai L.The efficacy of scar softening liquid to control the hypertrophic scar [in Chinese]. J Chin Plast Surg. 1993 ;9:316-320.
34.
Wei W., Li-Jun H., Jie W., et al. The effect of tamoxifen on the hypertrophic scar in rabbit ear [in Chinese]. Hei Long Jiang Med J. 2005;29:821-823.
35.
Shen DP, Ju Q., Cao YH, et al. The development of drug therapy for scar treatment. Dermatol Venereol. 2002;28: 10-13.
36.
Hong CJ, Xue ZZModern Treatment of Scars. Beijing, China: People's Health Press; 2000.
37.
Ni YY, Qiang HJ1 Case of side effects of thiotepa + triamcinolone aeetortide + lidocaine to treat keloids [in Chinese]. Chin J Clin Med Res. 2005;140:15251-15256.
38.
Cosman B., Crikelair GF, Ju DM, Gaulin JC, Lattes R.The surgical treatment of keloids. Plast Reconstr Surg. 1961;27:335-355.
39.
Berman B., Bieley HCAdjunct therapies to surgical management of keloids. Dermatol Surg. 1996;22:126-130.
40.
Zhi GXTumor Radiation Therapeutics [in Chinese]. Beijing , China: Beijing Medical University and Peking Union Medical College in China Joint Press.
41.
King GD, Salzman FAKeloid scars analysis of 89 patients. Surg Clin North Am. 1970;50:595-598.
42.
De Beurman R., Gougerot H.Cheloides des muquescies. Ann Dermatol Syph. 1906;7:151-156.
43.
Ollstein RN , Siegel HW, Gillooley JF, et al. Treatment of keloids by combined surgical excision and immediate postoperative x-ray therapy . Ann Plast Surg. 1981;7:281-285.
44.
Kovalic JJ, Perez CARadiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys. 1989;17:77-80.
45.
Ogawa R., Mitsuhashi K., Hyakusoku H., et al. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111: 547-553.
46.
Sclafani AP , Gordon L., Chadha M., et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature . Dermatol Surg . 1996;22:569-574.
47.
Yamaguchi H.Light and electron microscope observation of the active peripheral regions of the keloids following electron ray irradiation . J Kanazawa Med Univ. 1995;20:70-80.
48.
Schmidt WF, Hohenberg G., Handl-Zeller L.Dose estimation in postoperative keloid irradiation with special consideration of ovarian dose. Onkologie. 1991;167: 534-537.
49.
Maarouf M., Schleicher U., Schmachtenberg A., Ammon J.Radiotherapy in the management of keloids: clinical experience with electron beam irradiation and comparison with X-ray therapy. Strahlenther Onkol. 2002;178: 330-335.
50.
Wagner W.Results of prophylactic irradiation in patients with resected keloid a retrospective analysis. Acta Oncol. 2000 ;39:217-220.
51.
Escarmant P. , Zimmermann S., Amar A., et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys. 1993 ;26:245-251.
52.
Guix B., Henríquez I., Andrés A., Finestres F., Tello JI, Martínez A.Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys. 2001 ;50:167-172.
53.
Ragoowansi R., Cornes PG, Moss AL, Glees JPTreatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy . Plast Reconstr Surg. 2003;111:1853-1859.
54.
Doombos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids . Int J Radiat Oncol Biol Phys.1990;18:833-839.
55.
Borok TL, Bray M., Sinclair I., et al. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys. 1988;15:865-870.
56.
Kovalic JJ, Perez CARadiation therapy following keloidectomy:a 20 year experience. Int J Radiat Oncol Biol Phys. 1989;17:77-80.
57.
Craig RD, Pearson D.Early post-operative irradiation in the treatment of keloid scars . Br J Plast Surg. 1965;18:369-376.
58.
Klumpar DIKeloids treated with excision followed by radiation therapy. J Am Acad Dermatol. 1994;31(2, pt 1): 225-231.
59.
Long FJ, Lan ZAThe combination of surgery with radiotherapy to treat 78 cases of keloid. J Mod Med. 2004;20:336-340.
60.
Huang LJ, Yun WL, Wei WXThe vale of radiotherapy on the scar tumor. J Chin Physician . 2005;7:382-383.
61.
Ogawa R., Mitsuhashi K., Hyakusoku H., et al. Postoperative radiation protocol for keloids and hypertrophic scars: statistical analysis of 370 sites followed for over 18 months. Plast Surg. 2007;59:688-691.
62.
Hoffman S.Radiotherapy for keloids. Ann Plast Surg. 1982;9:265-266.
63.
Botwood N., Lewanski C., Lowdell C.The risk of treating keloids with radiotherapy. Br J Radiol . 1999;72:1222-1224.
64.
Niessen FB, Spauwen PH, Schalkwijk J., Kon M.On the nature of hypertrophic.scars and keloids: a review. Plast Reconstr Surg.1999;104:1435-1458.
65.
Baker BL, Whitaker WLInterference with wound healing by local action of adrenal corticosteroids . Endocrinology. 1950;46:544-551.
66.
Murray RDKenalog and the treatment of hypertrophied scars in negroes and whites . Plast Reconstr Surg. 1963;31:275-280.
67.
Ketchum LD, Robinson DW, Masters FWThe treatment of hypertrophic scar, keloid, and scar contracture by triamcinolone acetonide. Plast Reconstr Surg. 1966;38: 209-218.
68.
Griffith BHThe treatment of keloids with tria mcinolone acetonide. Plast Reconstr Surg. 1966;38: 202-208.
69.
Cohen JK, Diegelmann RFThe biology of keloid and hypertrophic scar and the influence of corticosteroids . Clin Plast Surg. 1977;4:297-299.
70.
Kauh YC, Rouda S., Mondragon G., et al. Major suppression of pro-alpha1(I)type I collagen gene expression in the dermis after keloid excision and immediate intra-wound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586-589.
